Searchable abstracts of presentations at key conferences in endocrinology

ea0011s104 | Presenting your research – getting your work known | ECE2006

Papers for peer reviewed journals

Pearce S

The most important part of any research project is getting it published in the best way; this usually will include a peer reviewed journal paper. Choice of journal is an important decision, with international broad readership journals having much greater prestige than regional or subject-restricted publications. You will need to decide whether to put all your relevant research findings into a single large manuscript, or to split your work up into a series of smaller papers. If...

ea0019p90 | Clinical practice/governance and case reports | SFEBES2009

On adequate thyroxine replacement and still symptomatic

Kamaruddin MS , Pearce SH

Hypothyroid patients often present with non-specific symptoms and some of these may persist despite adequate thyroxine replacement, including weakness, poor memory, paraesthesia and numbness or coldness of the extremities. In patients on thyroxine who have been referred due to persistent symptoms, we routinely look for vitamin B12 deficiency, if symptoms persist once thyroxine replacement has been optimised.We present three patients who remained symptoma...

ea0080OC3 | Oral Communications | UKINETS2021

An update on the effects of debulking surgery and liver directed intra-arterial therapies on quality of life in patients with metastatic neuroendocrine tumours

Woods Eleanor , Sinclair Adam , Jarvis Emma , Ramsey Emma , Tanno Lulu , Naheed Salma , Armstrong Thomas , Takhar Arjun , Knight John , Stedman Brian , Modi Sachin , Bryant Timothy , Breen David , Nolan Luke , Al-Mrayat Ma'en , Pearce Neil , Cave Judith

Background: Neuroendocrine tumours (NETs) arise from neuroendocrine cells, they are commonly found in the pancreas, small bowel and lung. They are a heterogeneous group of tumours capable of secreting a variety of hormones, therefore the spectrum of symptoms is broad. Treatment options for metastatic NETs include cytoreductive surgery, or interventional radiology procedures such as transarterial embolization (TAE). Aims: Previous studies have shown that ...

ea0077lb38 | Late Breaking | SFEBES2021

An interesting case of Hypophosphataemia: Oncogenic Osteomalacia

Pervez Muhammad Hassaan , Pearce Simon , Artham Satish

Introduction: Causes of hypophosphataemia include reduced intestinal absorption, inadequate intake, transcellular shifts (refeeding syndrome, glucose/insulin infusion), renal loss which is either FGF23 mediated (inherited forms or tumour induced osteomalacia) or non-FGF23 mediated (hyperparathyroidism, drugs)Case report: We present a case of 51 years old female referred to us with multiple fractures during her half marathon. She suffered from bilateral m...

ea0038p332 | Pituitary | SFEBES2015

Loperamide-induced hypopituitarism

Napier Catherine , Pearce Simon H S

Loperamide is a poorly absorbed opioid μ-receptor agonist that is the most commonly used anti-diarrhoeal medication in the UK. Prescription cost analysis from the Department of Health and Social Care Information Centre reported that 1.79 million prescriptions of the drug were issued in 2014 and it is also freely available ‘over the counter’. It is widely believed to be very safe, with constipation as the main side-effect.A 45-year-old man ...

ea0038p432 | Thyroid | SFEBES2015

Peripheral blood microRNA markers in patients with papillary thyroid cancer

Perros Petros , Mallick Ujjal , Pearce Simon

Monitoring patients with thyroid cancer for recurrent disease relies heavily on measuring serum thyroglobulin (Tg). Tg cannot be assessed reliably in the presence of anti-thyroglobulin antibodies for analytical reasons, this being the case in about a third of patients. There has been recent interest in microRNA profiling of fine needle aspiration biopsies of thyroid nodules, with encouraging results. The objective of this pilot was to explore microRNAs in peripheral blood of p...

ea0013p37 | Clinical practice/governance and case reports | SFEBES2007

Shrinking adrenal mass: Case report of an adrenal pseudocyst

Ravikumar Balasubramanian , Lennard Tom , Pearce Simon

A previously fit 39 year old joiner presented in November 2003 with a 6 month history of intermittent right-sided abdominal pain. There was no associated nausea or vomiting. An abdominal ultrasound requested by his general practitioner revealed a single gallbladder calculus and a 10 cm right-sided cystic mass with some echogenic areas, probably of hepatic or adrenal origin. He was normotensive and clinical examination was normal. CT scan of the abdomen confirmed a 9 cm mass ar...

ea0013p242 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Subclinical hypothyroidism is associated with increased cardiovascular risk: A meta-analysis

Razvi Salman , Weaver Jolanta , Pearce Simon

There are discrepancies between different studies with regards to the association of subclinical hypothyroidism (SCH), dyslipidaemia and cardiovascular (CV) disease. Therefore, we have conducted a systematic search and meta-analysis of population-based studies of CV disease in which thyroid status was examined and randomised controlled trials (RCTs) of treatment.The PubMed and Embase databases were searched for relevant studies published between 1976 and...

ea0012p133 | Thyroid | SFE2006

Does L-thyroxine reduce weight in people with subclinical hypothyroidism?

Razvi S , Pearce SH , Weaver JU

ObjectiveIt is controversial whether subclinical hypothyroidism (SCH) always reflects mild thyroid failure and if treatment is beneficial. The arguments in favour of treatment are prevention of progression, reducing cholesterol levels and improving symptoms. The consequence of SCH on body weight and its response to treatment has never been studied in a systematic manner.MethodsUnselected population-based stud...

ea0010p2 | Bone | SFE2005

Investigation and management of hypophosphataemic rickets in infancy

Ibrahim I , Cheetham T , Pearce S

Introduction: The biochemical diagnosis of hypophosphataemic rickets relies on measurement of tubular phosphate reabsorption. However, as the renal tubules are immature at birth and the reference range for urine phosphate excretion is not well defined in young children, there is uncertainty about how early in life a biochemical diagnosis of phosphate wasting can be made. In addition, the benefit of early treatment of hypophosphataemic rickets is unclear.<p class="ab...